Ardent Health, Inc. (NYSE:ARDT - Get Free Report) rose 4.3% on Friday. The company traded as high as $15.10 and last traded at $15.12. Approximately 657,229 shares traded hands during mid-day trading, an increase of 25% from the average session volume of 526,928 shares. The stock had previously closed at $14.50.
Analyst Upgrades and Downgrades
ARDT has been the topic of several research analyst reports. The Goldman Sachs Group reissued a "neutral" rating and set a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of Ardent Health from a "sell (d+)" rating to a "hold (c)" rating in a research report on Monday, November 9th. Stephens upped their price objective on Ardent Health from $13.00 to $21.00 and gave the stock an "overweight" rating in a report on Friday, November 6th. Royal Bank Of Canada upped their price objective on Ardent Health from $13.00 to $18.00 and gave the stock an "outperform" rating in a report on Friday, November 6th. Finally, Bank of America increased their price objective on Ardent Health from $12.00 to $14.00 and gave the company an "underperform" rating in a research report on Friday, November 13th. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $15.68.
Get Our Latest Stock Analysis on ARDT
Ardent Health Stock Up 3.7%
The firm's 50 day moving average price is $12.56 and its 200-day moving average price is $10.49. The company has a current ratio of 2.13, a quick ratio of 2.03 and a debt-to-equity ratio of 0.60. The company has a market cap of $2.12 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 2.62 and a beta of 0.58.
Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.08. The firm had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.60 billion. Ardent Health had a net margin of 2.27% and a return on equity of 8.41%. As a group, equities research analysts expect that Ardent Health, Inc. will post 1.04 EPS for the current year.
Institutional Trading of Ardent Health
A number of institutional investors and hedge funds have recently modified their holdings of ARDT. Wedge Capital Management L L P NC raised its position in shares of Ardent Health by 212.3% during the second quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company's stock worth $3,220,000 after purchasing an additional 222,447 shares during the period. Ieq Capital LLC bought a new position in shares of Ardent Health during the 2nd quarter valued at about $907,000. Bank of New York Mellon Corp acquired a new position in shares of Ardent Health in the 2nd quarter valued at approximately $2,377,000. Hsbc Holdings PLC acquired a new position in shares of Ardent Health in the 2nd quarter valued at approximately $543,000. Finally, BlackRock Inc. bought a new stake in Ardent Health during the 2nd quarter worth approximately $21,415,000.
About Ardent Health
(
Get Free Report)
Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.